Logo image of NRDS

NERDWALLET INC-CL A (NRDS) Stock Fundamental Analysis

NASDAQ:NRDS - Nasdaq - US64082B1026 - Common Stock - Currency: USD

9.03  +0.07 (+0.78%)

After market: 9.03 0 (0%)

Fundamental Rating

5

Taking everything into account, NRDS scores 5 out of 10 in our fundamental rating. NRDS was compared to 52 industry peers in the Consumer Finance industry. NRDS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. NRDS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NRDS was profitable.
NRDS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NRDS reported negative net income in multiple years.
NRDS had a positive operating cash flow in each of the past 5 years.
NRDS Yearly Net Income VS EBIT VS OCF VS FCFNRDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

NRDS has a Return On Assets of 6.95%. This is amongst the best in the industry. NRDS outperforms 82.69% of its industry peers.
NRDS has a Return On Equity (8.35%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 1.97%, NRDS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA 6.95%
ROE 8.35%
ROIC 1.97%
ROA(3y)0.58%
ROA(5y)-1.57%
ROE(3y)0.72%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
NRDS Yearly ROA, ROE, ROICNRDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

NRDS's Profit Margin of 4.42% is on the low side compared to the rest of the industry. NRDS is outperformed by 73.08% of its industry peers.
In the last couple of years the Profit Margin of NRDS has declined.
NRDS's Operating Margin of 1.37% is on the low side compared to the rest of the industry. NRDS is outperformed by 61.54% of its industry peers.
NRDS's Operating Margin has declined in the last couple of years.
NRDS has a Gross Margin of 90.77%. This is amongst the best in the industry. NRDS outperforms 82.69% of its industry peers.
NRDS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.37%
PM (TTM) 4.42%
GM 90.77%
OM growth 3YN/A
OM growth 5Y-35.7%
PM growth 3YN/A
PM growth 5Y-16.05%
GM growth 3Y-0.63%
GM growth 5Y-0.47%
NRDS Yearly Profit, Operating, Gross MarginsNRDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

NRDS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NRDS has less shares outstanding
NRDS has more shares outstanding than it did 5 years ago.
NRDS has a worse debt/assets ratio than last year.
NRDS Yearly Shares OutstandingNRDS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
NRDS Yearly Total Debt VS Total AssetsNRDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NRDS has an Altman-Z score of 6.94. This indicates that NRDS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.94, NRDS belongs to the top of the industry, outperforming 96.15% of the companies in the same industry.
NRDS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.94
ROIC/WACC0.22
WACC8.85%
NRDS Yearly LT Debt VS Equity VS FCFNRDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.27 indicates that NRDS has no problem at all paying its short term obligations.
NRDS has a better Current ratio (3.27) than 80.77% of its industry peers.
A Quick Ratio of 3.27 indicates that NRDS has no problem at all paying its short term obligations.
NRDS has a better Quick ratio (3.27) than 82.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
NRDS Yearly Current Assets VS Current LiabilitesNRDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

6

3. Growth

3.1 Past

NRDS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 450.00%, which is quite impressive.
Measured over the past 5 years, NRDS shows a small growth in Earnings Per Share. The EPS has been growing by 0.81% on average per year.
NRDS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.71%.
Measured over the past years, NRDS shows a very strong growth in Revenue. The Revenue has been growing by 24.67% on average per year.
EPS 1Y (TTM)450%
EPS 3YN/A
EPS 5Y0.81%
EPS Q2Q%5200%
Revenue 1Y (TTM)14.71%
Revenue growth 3Y21.9%
Revenue growth 5Y24.67%
Sales Q2Q%37.47%

3.2 Future

NRDS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.52% yearly.
NRDS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.39% yearly.
EPS Next Y-35.95%
EPS Next 2Y16.47%
EPS Next 3Y16.52%
EPS Next 5YN/A
Revenue Next Year12.92%
Revenue Next 2Y10.62%
Revenue Next 3Y8.29%
Revenue Next 5Y6.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NRDS Yearly Revenue VS EstimatesNRDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
NRDS Yearly EPS VS EstimatesNRDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.43, which indicates a rather expensive current valuation of NRDS.
NRDS's Price/Earnings ratio is a bit more expensive when compared to the industry. NRDS is more expensive than 67.31% of the companies in the same industry.
NRDS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.85, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 28.77, NRDS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NRDS indicates a slightly more expensive valuation: NRDS is more expensive than 71.15% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of NRDS to the average of the S&P500 Index (20.77), we can say NRDS is valued slightly more expensively.
Industry RankSector Rank
PE 18.43
Fwd PE 28.77
NRDS Price Earnings VS Forward Price EarningsNRDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

78.85% of the companies in the same industry are more expensive than NRDS, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as NRDS.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 10.32
NRDS Per share dataNRDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as NRDS's earnings are expected to grow with 16.52% in the coming years.
PEG (NY)N/A
PEG (5Y)22.65
EPS Next 2Y16.47%
EPS Next 3Y16.52%

0

5. Dividend

5.1 Amount

No dividends for NRDS!.
Industry RankSector Rank
Dividend Yield N/A

NERDWALLET INC-CL A

NASDAQ:NRDS (5/1/2025, 9:20:55 PM)

After market: 9.03 0 (0%)

9.03

+0.07 (+0.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners83.22%
Inst Owner Change-0.02%
Ins Owners6.28%
Ins Owner Change1.42%
Market Cap672.64M
Analysts81.54
Price Target16.83 (86.38%)
Short Float %6.58%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2342.78%
Min EPS beat(2)168.76%
Max EPS beat(2)4516.81%
EPS beat(4)3
Avg EPS beat(4)1142.77%
Min EPS beat(4)-125.51%
Max EPS beat(4)4516.81%
EPS beat(8)5
Avg EPS beat(8)546.69%
EPS beat(12)7
Avg EPS beat(12)374.71%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)8.73%
Min Revenue beat(2)6.9%
Max Revenue beat(2)10.57%
Revenue beat(4)3
Avg Revenue beat(4)4.23%
Min Revenue beat(4)-1.64%
Max Revenue beat(4)10.57%
Revenue beat(8)5
Avg Revenue beat(8)2.16%
Revenue beat(12)8
Avg Revenue beat(12)2.12%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-227.32%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 18.43
Fwd PE 28.77
P/S 0.98
P/FCF 13.32
P/OCF 9.37
P/B 1.85
P/tB 3.08
EV/EBITDA 10.32
EPS(TTM)0.49
EY5.43%
EPS(NY)0.31
Fwd EY3.48%
FCF(TTM)0.68
FCFY7.51%
OCF(TTM)0.96
OCFY10.67%
SpS9.23
BVpS4.89
TBVpS2.93
PEG (NY)N/A
PEG (5Y)22.65
Profitability
Industry RankSector Rank
ROA 6.95%
ROE 8.35%
ROCE 2.49%
ROIC 1.97%
ROICexc 2.4%
ROICexgc 4.55%
OM 1.37%
PM (TTM) 4.42%
GM 90.77%
FCFM 7.34%
ROA(3y)0.58%
ROA(5y)-1.57%
ROE(3y)0.72%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-36.98%
ROICexc growth 3YN/A
ROICexc growth 5Y-44.38%
OM growth 3YN/A
OM growth 5Y-35.7%
PM growth 3YN/A
PM growth 5Y-16.05%
GM growth 3Y-0.63%
GM growth 5Y-0.47%
F-Score7
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.01%
Cap/Sales 3.1%
Interest Coverage 31.33
Cash Conversion 124.22%
Profit Quality 166.12%
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z 6.94
F-Score7
WACC8.85%
ROIC/WACC0.22
Cap/Depr(3y)64.08%
Cap/Depr(5y)80.19%
Cap/Sales(3y)4.66%
Cap/Sales(5y)5.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)450%
EPS 3YN/A
EPS 5Y0.81%
EPS Q2Q%5200%
EPS Next Y-35.95%
EPS Next 2Y16.47%
EPS Next 3Y16.52%
EPS Next 5YN/A
Revenue 1Y (TTM)14.71%
Revenue growth 3Y21.9%
Revenue growth 5Y24.67%
Sales Q2Q%37.47%
Revenue Next Year12.92%
Revenue Next 2Y10.62%
Revenue Next 3Y8.29%
Revenue Next 5Y6.39%
EBIT growth 1Y88%
EBIT growth 3YN/A
EBIT growth 5Y-19.84%
EBIT Next Year3573.72%
EBIT Next 3Y287.17%
EBIT Next 5Y132.81%
FCF growth 1Y18.54%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y-0.42%
OCF growth 3Y115.24%
OCF growth 5Y17.99%